Femta Pharmaceuticals signed a manufacturing services and license agreement with Lonza for its lead humanized interleukin 6 mAb called FM101. Femta says that it aims to submit an IND for the rheumatoid arthritis candidate...
Officials at TAP Biosystems say they have agreed to collaborate with Life Technologies on the development a cost-efficient, high-throughput protein expression platform.
Cellular input and output revised with modular synthetic biology components to sensitize immune cells to a tumor signal
Evolution causes the rise of unproductive microbial variants in large-scale bioproduction processes, necessitating strategies to pause productivity-degrading evolutionary mechanisms
KAHR to start clinical trials with RA candidate in 2010. The trans signal converter proteins are a therapeutic with two functional sides.
Procedure uses proton beams to destroy diseased tissue for regeneration using ASCs developed in NASA-designed bioreactor.
Scientists show that three factor-transduced MEFs can reprogram to iPSCs in suspension.
Purolite and Codexis are collaborating to develop and market immobilized enzymes for the pharmaceutical industry.
A rogue ribosome, finished with translating the coding sequence of messenger RNA, and unwilling to await recycling, starts working in the so-called untranslated region.
Please wait while you are redirected to the right page...